ClinicalTrials.gov
public full text
Public Domain
Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease
In this application the investigators describe plans for a randomized controlled cross-over trial to determine the effects of omega-3 fatty acid supplementation on urine protein excretion in 30 adults with diabetes (NIDDM) and kidney disease defined by the presence of proteinuria.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria#1085947
- The albumin-bilirubin score is associated with renal decline in diabetic kidney disease: a retrospective study.#465074
- Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes#856808
- Dapagliflozin Treatment in Type 2 Diabetes#811709
- Delaying the Progression of Diabetic Nephropathy in Pima Indians#860036
Record · ID 854485
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive